METFORMIN HYDROCHLORIDE | N021748 | SANTARUS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D.N.J. | 2019-06-28 | Terminated 2019-09-05 | — | |
Depomed Inc. v. Watson Laboratories Inc. - Florida et al 4 patentsANDA 203755metformin hydrochloride extended release | D. Del. | 2013-02-28 | Terminated 2014-01-07 | — |
Depomed Inc. et al v. Watson Laboratories Inc. Florida et al 2 patentsANDA 203755metformin hydrochloride extended release | D. Del. | 2012-04-18 | Terminated 2014-01-07 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Senores Pharmaceuticals, Inc. FDA-2026-P-3798 · 2 docket documents Senores Pharmaceuticals, Inc. filed this citizen petition pursuant to sections 505(j) and 505(w) of the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. §§ 314.122 and 314.161 requesting that the FDA determine whether GLUMETZA (metformin hydrochloride extended-release tablets, 500 mg and 1 gram), | 505(q) | 2026-04-07 | Open | Senores Pharmaceuticals, Inc. |
Citizen Petition from Hyman, Phelps & McNamara, PC FDA-2018-P-3327 · 9 docket documents Hyman, Phelps & McNamara, P.C., on behalf of a client, submitted this petition pursuant to section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. § 314.93 requesting that the FDA determine that Metformin Hydrochloride Granules for Oral Solution in 500 mg, 850 mg, and 1 g stre | Other | 2018-08-31 | Open | Hyman, Phelps & McNamara, PC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.